Clinical Outcome Assessments (COA) Frequently Asked Questions
Similar Posts
Nat’s Nuts Issues Allergy Alert on Potential Undeclared Cashews in Nat’s Nuts Brand Cinnamon Whiskey Pecans
Nat’s Nuts of Rochester, NY is recalling 600 bags of Cinnamon Whiskey Pecans, because they may contain undeclared cashews. People who have an allergy or severe sensitivity to cashews run the risk of serious or life-threatening allergic reaction if they consume these products.FDA Approves First Treatment for Children With Menkes Disease
The U.S. Food and Drug Administration today approved the Zycubo (copper histidinate) injection as the first treatment for Menkes disease in pediatric patients.Study of Sex Differences in the Clinical Evaluation of Medical Products
This guidance provides recommendations for increasing enrollment of females in clinical trials, analyzing and interpreting sex-specific data, and including sex-specific information in regulatory submissions of medical productsCoronavirus Aid, Relief, and Economic Security Act (CARES Act) Drug Shortage Mitigation Efforts
The Coronavirus Aid, Relief, and Economic Security Act (CARES Act) was signed into law on March 27, 2020 to aid response efforts and ease the economic impact of COVID-19.Brands International Corporation – 06/21/2024
Brands International Corporation – 06/21/2024. Country: Canada. Record Type: 483Advisory Letters
Advisory Letters